Research Article
BibTex RIS Cite

Knowledge level about HPV infection and cervical cancer screening tests

Year 2023, , 949 - 953, 30.09.2023
https://doi.org/10.16899/jcm.1347031

Abstract

Introduction: Understanding HPV and cervical cancer is vital for prevention, early diagnosis, and treatment. Nurses play a crucial role in implementing screening and are also at risk. This study examines nurses' knowledge and practices regarding HPV and cervical cancer screening in a tertiary center.
Materials and Methods: It is a prospective survey study conducted with nurses. A total of 191 nurses participated in the three-part and 53-item survey that evaluated demographic data, HPV knowledge levels and cervical cancer screening awareness.
Results: A total of 2895 nurses work at the hospital. The rate of participation in the research was 6.6% with 191 participants. The average age of the participants is 27.1. Majority of the participants are female (n: 171, 89.5%), only 20 (10.5%) are male. While 81.9% of the respondents had knowledge about sexually transmitted diseases, only 13.5% had gone to regular gynecological examinations. Despite 98.4% of the participants who had knowledge about cervical cancer and screening practices, only 11% (n:19) had undergone cervical cancer screening and 94.2% (n:180) had not received HPV vaccine. The most mis-answered question about HPV was whether current vaccines protect against both genital warts and cervical cancer.
Conclusion: In conclusion, nurses' knowledge level and screening practices about HPV and cervical cancer need to be improved. It is also important to increase awareness of the HPV vaccine and encourage more people to receive it. This effort could positively impact health outcomes related to cervical cancer and HPV.

References

  • 1. De Sanjosé S, Diaz M, Castellsagué X, et al. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. The Lancet infectious diseases 2007;7(7):453-459.
  • 2. An HJ, Cho NH, Lee SY, et al. Correlation of cervical carcinoma and precancerous lesions with human papillomavirus (HPV) genotypes detected with the HPV DNA chip microarray method. Cancer: Interdisciplinary International Journal of the American Cancer Society 2003;97(7):1672-1680.
  • 3. Kessler TA. Cervical cancer: prevention and early detection. Seminars in oncology nursing: Elsevier; 2017:172-183.
  • 4. Schwarz TF, Huang L-M, Valencia A, et al. A ten-year study of immunogenicity and safety of the AS04-HPV-16/18 vaccine in adolescent girls aged 10-14 years. Human vaccines & immunotherapeutics 2019;15(7-8):1970-1979.
  • 5. Castellsagué X. Natural history and epidemiology of HPV infection and cervical cancer. Gynecologic oncology 2008;110(3):S4-S7.
  • 6. Dunne EF, Unger ER, Sternberg M, et al. Prevalence of HPV infection among females in the United States. Jama 2007;297(8):813-819.
  • 7. Findik S, Findik S, Abuoğlu S, Cihan FG, Ilter H, Iyisoy MS. Human papillomavirus (HPV) subtypes and their relationships with cervical smear results in cervical cancer screening: a community-based study from the central Anatolia region of Turkey. International Journal of Clinical and Experimental Pathology 2019;12(4):1391.
  • 8. McCormack PL. Quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine (Gardasil®): a review of its use in the prevention of premalignant anogenital lesions, cervical and anal cancers, and genital warts. Drugs 2014;74(11):1253-1283.
  • 9. Pennella RA, Ayers KA, Brandt HM. Understanding how adolescents think about the HPV vaccine. Vaccines 2020;8(4):693.
  • 10. Chelimo C, Wouldes TA, Cameron LD, Elwood JM. Risk factors for and prevention of human papillomaviruses (HPV), genital warts and cervical cancer. Journal of Infection 2013;66(3):207-217.
  • 11. Kilic D, Dolma E, GÜNEY İ, et al. Knowledge level and attitude for Human Papillomavirus (HPV) infection and HPV vaccines among medical school students. Journal of Contemporary Medicine 2020;10(3):394-398.
  • 12. Genc RE, Sarican ES, Turgay AS, Icke S, Sari D, Saydam BK. Determination of knowledge of Turkish midwifery students about human papilloma virus infection and its vaccines. Asian Pacific Journal of Cancer Prevention 2013;14(11):6775-6778.
  • 13. Ljubojevic S, Skerlev M. HPV-associated diseases. Clinics in dermatology 2014;32(2):227-234.
  • 14. Petry KU. HPV and cervical cancer. Scandinavian Journal of Clinical and Laboratory Investigation 2014;74(sup244):59-62.
  • 15. Prétet JL, Jacquard AC, Carcopino X, et al. Human papillomavirus (HPV) genotype distribution in invasive cervical cancers in France: EDITH study. International journal of cancer 2008;122(2):428-432.
  • 16. Buskwofie A, David-West G, Clare CA. A Review of Cervical Cancer: Incidence and Disparities. J Natl Med Assoc 2020;112(2):229-232. (In eng). DOI: 10.1016/j.jnma.2020.03.002.
  • 17. Catarino R, Petignat P, Dongui G, Vassilakos P. Cervical cancer screening in developing countries at a crossroad: Emerging technologies and policy choices. World J Clin Oncol 2015;6(6):281-90. (In eng). DOI: 10.5306/wjco.v6.i6.281.
  • 18. Narasimhamurthy M, Kafle SU. Cervical cancer in Nepal: Current screening strategies and challenges. Front Public Health 2022;10:980899. (In eng). DOI: 10.3389/fpubh.2022.980899.
  • 19. Ali S, Skirton H, Clark MT, Donaldson C. Integrative review of cervical cancer screening in Western Asian and Middle Eastern Arab countries. Nurs Health Sci 2017;19(4):414-426. (In eng). DOI: 10.1111/nhs.12374.
  • 20. SATILMIŞOĞLU ZZ, ASLAN İÖ, Nebibe C, GÜLCİVAN G, YILDIZ T, ŞENTÜRK M. Kız çocuk ebeveyni hemşire annelerin HPV aşısı hakkında bilgi düzeyi: Namık Kemal Üniversitesi Sağlık Uygulama ve Araştırma Merkezi anket çalışması. Namık Kemal Tıp Dergisi 2018;6(3):104-108.

HPV Enfeksiyonu ve Rahim Ağzı Kanseri Tarama Testleri Hakkında Bilgi Düzeyi

Year 2023, , 949 - 953, 30.09.2023
https://doi.org/10.16899/jcm.1347031

Abstract

Giriş: HPV ve rahim ağzı kanserini anlamak, önleme, erken teşhis ve tedavi için hayati öneme sahiptir. Hemşireler, taramanın uygulanmasında çok önemli bir rol oynar ve aynı zamanda risk altındadır. Bu çalışma, üçüncü basamak bir merkezde hemşirelerin HPV ve rahim ağzı kanseri taramasına ilişkin bilgi ve uygulamalarını incelemektedir.
Gereç ve Yöntem: Hemşireler ile gerçekleştirilen prospektif bir anket çalışmasıdır. Demografik verileri, HPV bilgi düzeylerini ve servikal kanser taraması farkındalığını değerlendiren, üç bölümden ve 53 sorudan oluşan ankete toplam 191 hemşire katılmıştır.
Bulgular: Hastanede toplam 2895 hemşire çalışmaktadır. Araştırmaya katılım oranı 191 katılımcı ile %6,6 oldu. Katılımcıların yaş ortalaması 27,1'dir. Katılımcıların çoğunluğu kadındır (n: 171, %89,5), sadece 20'si (%10,5) erkektir. Katılımcıların %81,9'u cinsel yolla bulaşan hastalıklar hakkında bilgi sahibiyken, sadece %13,5'i düzenli jinekolojik muayeneye gitmiştir. Katılımcıların %98,4'ü rahim ağzı kanseri ve tarama uygulamaları hakkında bilgi sahibi olmasına rağmen, sadece %11'i (n:19) rahim ağzı kanseri taraması yaptırmış ve %94,2'si (n:180) HPV aşısı yaptırmamıştı. HPV ile ilgili en yanlış cevaplanan soru, mevcut aşıların hem genital siğillere hem de rahim ağzı kanserine karşı koruma sağlayıp sağlamadığıydı.
Sonuç: Sonuç olarak, hemşirelerin HPV ve rahim ağzı kanseri ile ilgili bilgi düzeylerinin ve tarama uygulamalarının geliştirilmesi gerekmektedir. HPV aşısı farkındalığını artırmak ve daha fazla insanı aşı olmaya teşvik etmek de önemlidir. Bu çaba, rahim ağzı kanseri ve HPV ile ilgili sağlık sonuçlarını olumlu yönde etkileyebilir.

References

  • 1. De Sanjosé S, Diaz M, Castellsagué X, et al. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. The Lancet infectious diseases 2007;7(7):453-459.
  • 2. An HJ, Cho NH, Lee SY, et al. Correlation of cervical carcinoma and precancerous lesions with human papillomavirus (HPV) genotypes detected with the HPV DNA chip microarray method. Cancer: Interdisciplinary International Journal of the American Cancer Society 2003;97(7):1672-1680.
  • 3. Kessler TA. Cervical cancer: prevention and early detection. Seminars in oncology nursing: Elsevier; 2017:172-183.
  • 4. Schwarz TF, Huang L-M, Valencia A, et al. A ten-year study of immunogenicity and safety of the AS04-HPV-16/18 vaccine in adolescent girls aged 10-14 years. Human vaccines & immunotherapeutics 2019;15(7-8):1970-1979.
  • 5. Castellsagué X. Natural history and epidemiology of HPV infection and cervical cancer. Gynecologic oncology 2008;110(3):S4-S7.
  • 6. Dunne EF, Unger ER, Sternberg M, et al. Prevalence of HPV infection among females in the United States. Jama 2007;297(8):813-819.
  • 7. Findik S, Findik S, Abuoğlu S, Cihan FG, Ilter H, Iyisoy MS. Human papillomavirus (HPV) subtypes and their relationships with cervical smear results in cervical cancer screening: a community-based study from the central Anatolia region of Turkey. International Journal of Clinical and Experimental Pathology 2019;12(4):1391.
  • 8. McCormack PL. Quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine (Gardasil®): a review of its use in the prevention of premalignant anogenital lesions, cervical and anal cancers, and genital warts. Drugs 2014;74(11):1253-1283.
  • 9. Pennella RA, Ayers KA, Brandt HM. Understanding how adolescents think about the HPV vaccine. Vaccines 2020;8(4):693.
  • 10. Chelimo C, Wouldes TA, Cameron LD, Elwood JM. Risk factors for and prevention of human papillomaviruses (HPV), genital warts and cervical cancer. Journal of Infection 2013;66(3):207-217.
  • 11. Kilic D, Dolma E, GÜNEY İ, et al. Knowledge level and attitude for Human Papillomavirus (HPV) infection and HPV vaccines among medical school students. Journal of Contemporary Medicine 2020;10(3):394-398.
  • 12. Genc RE, Sarican ES, Turgay AS, Icke S, Sari D, Saydam BK. Determination of knowledge of Turkish midwifery students about human papilloma virus infection and its vaccines. Asian Pacific Journal of Cancer Prevention 2013;14(11):6775-6778.
  • 13. Ljubojevic S, Skerlev M. HPV-associated diseases. Clinics in dermatology 2014;32(2):227-234.
  • 14. Petry KU. HPV and cervical cancer. Scandinavian Journal of Clinical and Laboratory Investigation 2014;74(sup244):59-62.
  • 15. Prétet JL, Jacquard AC, Carcopino X, et al. Human papillomavirus (HPV) genotype distribution in invasive cervical cancers in France: EDITH study. International journal of cancer 2008;122(2):428-432.
  • 16. Buskwofie A, David-West G, Clare CA. A Review of Cervical Cancer: Incidence and Disparities. J Natl Med Assoc 2020;112(2):229-232. (In eng). DOI: 10.1016/j.jnma.2020.03.002.
  • 17. Catarino R, Petignat P, Dongui G, Vassilakos P. Cervical cancer screening in developing countries at a crossroad: Emerging technologies and policy choices. World J Clin Oncol 2015;6(6):281-90. (In eng). DOI: 10.5306/wjco.v6.i6.281.
  • 18. Narasimhamurthy M, Kafle SU. Cervical cancer in Nepal: Current screening strategies and challenges. Front Public Health 2022;10:980899. (In eng). DOI: 10.3389/fpubh.2022.980899.
  • 19. Ali S, Skirton H, Clark MT, Donaldson C. Integrative review of cervical cancer screening in Western Asian and Middle Eastern Arab countries. Nurs Health Sci 2017;19(4):414-426. (In eng). DOI: 10.1111/nhs.12374.
  • 20. SATILMIŞOĞLU ZZ, ASLAN İÖ, Nebibe C, GÜLCİVAN G, YILDIZ T, ŞENTÜRK M. Kız çocuk ebeveyni hemşire annelerin HPV aşısı hakkında bilgi düzeyi: Namık Kemal Üniversitesi Sağlık Uygulama ve Araştırma Merkezi anket çalışması. Namık Kemal Tıp Dergisi 2018;6(3):104-108.
There are 20 citations in total.

Details

Primary Language English
Subjects Gynecologic Oncology Surgery
Journal Section Original Research
Authors

Merve Aldıkaçtıoğlu Talmaç 0000-0001-7219-1772

Nazlı Aylin Vural 0000-0003-0493-5439

Zeliha Zeynep Satılmışoğlu 0000-0001-5582-8102

Füreya Zilal Hocagil 0009-0003-0307-7986

Merve Atasoy Rusen 0009-0006-6542-9408

Nilüfer Çetinkaya 0000-0001-9183-3558

Publication Date September 30, 2023
Acceptance Date September 20, 2023
Published in Issue Year 2023

Cite

AMA Aldıkaçtıoğlu Talmaç M, Vural NA, Satılmışoğlu ZZ, Hocagil FZ, Atasoy Rusen M, Çetinkaya N. Knowledge level about HPV infection and cervical cancer screening tests. J Contemp Med. September 2023;13(5):949-953. doi:10.16899/jcm.1347031